首页> 美国卫生研究院文献>other >NO Binding to Mn-Substituted Homoprotocatechuate 23-Dioxygenase: Relationship to O2 Reactivity
【2h】

NO Binding to Mn-Substituted Homoprotocatechuate 23-Dioxygenase: Relationship to O2 Reactivity

机译:NO绑定到锰取代的homomotoprotocatechuate 23-双加氧酶:与O2反应性的关系。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Homoprotocatechuate 2,3-dioxygenase (FeHPCD) activates O2 to catalyze the aromatic ring opening of 3,4-dihydroxyphenylacetic acid (HPCA). The enzyme requires FeII for catalysis, but MnII can be substituted (MnHPCD) with essentially no change in the steady-state kinetic parameters. Near simultaneous O2 and HPCA activation has been proposed to occur through transfer of an electron(s) from HPCA to O2 through the divalent metal. In O2 reactions with MnHPCD-HPCA and the 4-nitrocatechol (4NC) complex of the His200Asn (H200N) variant of FeHPCD, this transfer has resulted in the detection of a transient MIII-O2•− species not observed during turnover of the wild type FeHPCD. The factors governing formation of the MIII-O2•− species are explored here with EPR spectroscopy using MnHPCD and nitric oxide (NO) as an O2 surrogate. Both the HPCA and dihydroxymandelic substrate complexes of MnHPCD bind NO, thus representing the first reported stable MnNO complexes of a nonheme enzyme. In contrast, the free enzyme, the MnHPCD-4NC complex, and the MnH200N and MnH200Q variants with or without HPCA bound do not bind NO. The MnHPCD-ligand complexes that bind NO are also active in normal O2-linked turnover, whereas the others are inactive. Past studies have shown that FeHPCD and the analogous variants and catecholic ligand complexes all bind NO, and are active in normal turnover. This contrasting behavior may stem from ability of the enzyme to maintain the ~0.8 V difference in the solution redox potentials of FeII and MnII. Due to the higher potential of Mn, the formation of the NO or O2 adduct requires both strong charge donation from the bound catecholic ligand and additional stabilization by interaction with the active site His200. The same non-optimal electronic and structural forces that prevent NO and O2 binding in MnHPCD variants may lead to inefficient electron transfer from the catecholic substrate to the metal center in variants of FeHPCD during O2-linked turnover. Accordingly, past studies have shown that intermediate FeIII species are observed for these mutant enzymes.
机译:同型儿茶酸2,3-二加氧酶(FeHPCD)激活O2,以催化3,4-二羟基苯基乙酸(HPCA)的芳族开环。该酶需要Fe II 进行催化,但是Mn II 可以被取代(MnHPCD),而稳态动力学参数基本不变。已经提出通过将电子从HPCA通过二价金属转移到O 2来发生几乎同时的O 2和HPCA活化。在与MnHPCD-HPCA和FeHPCD的His200Asn(H200N)变体的4-硝基邻苯二酚(4NC)络合物进行O2反应中,这种转移导致检测到瞬时M III -O2 在野生型FeHPCD转换过程中未观察到•− 种。本文利用MnHPCD和一氧化氮(NO)作为O2替代物,通过EPR光谱研究了控制M III -O2 •-物种形成的因素。 MnHPCD的HPCA和二羟基扁桃酸底物复合物都结合NO,因此代表了第一个报道的非血红素酶稳定MnNO复合物。相反,游离酶,MnHPCD-4NC复合物以及结合或不结合HPCA的MnH200N和MnH200Q变体不结合NO。结合NO的MnHPCD-配体复合物在正常的O2连锁转换中也有活性,而其他则无活性。过去的研究表明,FeHPCD及其类似变体和幼稚配体复合物均结合NO,并在正常周转中具有活性。这种相反的行为可能是由于酶在Fe II 和Mn II 的溶液氧化还原电位中维持〜0.8 V差异的能力所致。由于Mn的电势较高,因此要形成NO或O2加合物,既需要结合的儿茶酚配体提供强电荷,又需要与活性位点His200相互作用进行额外的稳定化处理。阻止MnHPCD变体中NO和O2结合的非最佳电子和结构力可能会导致在O2关联的转换过程中,FeHPCD变体中的电子从the基基质转移到金属中心的效率低下。因此,过去的研究表明,对于这些突变酶,观察到了中间的Fe III

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号